Century Therapeutics develops allogeneic cell therapies to treat various types of cancers, focusing on solid tumors and hematological malignancies. Its lead product is CNTY-101, an allogeneic CAR-iNK cell therapy that targets CD19 for relapsed B-cell lymphoma. The company has also developed several other product candidates for different types of cancers.
Address:25 North 38th Street, Philadelphia, PA, United States, 19104
About
Century Therapeutics develops allogeneic cell therapies to treat various types of cancers, focusing on solid tumors and hematological malignancies. Its lead product is CNTY-101, an allogeneic CAR-iNK cell therapy that targets CD19 for relapsed B-cell lymphoma. The company has also developed several other product candidates for different types of cancers.